The EAHL Interest Group on Supranational Biolaw

The EAHL Interest Group on Supranational Biolaw is co-chaired by Aurélie Mahalatchimy (UMR 7318 DICE CERIC, CNRS, Aix Marseille University, Toulon University, Pau & Pays de l’Adour University, France) and Mark Flear (Queen’s University Belfast, UK). The group has been created in 2020.

The EAHL Interest Group on Supranational Biolaw has been created in 2020. It aims to promote European health law, especially in its European-level dimension. ‘Supranational biolaw’ is understood as comprising the law of the European Union, the Council of Europe and the European Patent Organisation, regarding the law and the various legal issues arising from technological advances related to medicine and biotechnology.

While Supranational Biolaw in all its dimensions is often not understood as valuable in and of itself, it underpins or is inflected within national law, and is now so developed that it can no longer be ignored.

Through research, training and networking activities, the types of activities that correspond to the activities of EAHL, the EAHL Interest Group on Supranational Biolaw will help to effectively mobilise its Members to address demands from several groups within society, including legislators and regulators, scientists (researchers and clinicians), and patients regarding Supranational Biolaw. The Interest Group will also help to strengthen the position of academics within national level systems and political contexts that threaten their autonomy and role as facilitators of freedom of discussion.

The EAHL Interest Group on Supranational Biolaw is co-chaired by Aurélie Mahalatchimy (UMR 7318 DICE CERIC, CNRS, Aix Marseille University, Toulon University, Pau & Pays de l’Adour University, France) and Mark Flear (Queen’s University Belfast, UK), and managed by Pascal Gauttier (UMR 7318 DICE CERIC).

Current members include: Dobrochna Bach-Golecka (Poland); Estelle Brosset (France); Joaquin Cayon (Spain); Brenda Daly (Ireland); Nathalie De Grove-Valdeyron (France); Anne-Marie Duguet (France); Mirko Dukovic (Hungary); Inesa Fausch (Switzerland); Mark Flear (United Kingdom); Markus Frischhut (Austria); Eloïse Gennet (France); Matthieu Guerriaud (France); Mary Guy (United Kingdom); Edouard Habib (France); Tamara Hervey (United Kingdom); Clotilde Jourdain-Fortier (France); Kaisa-Maria Kimmel (Finland); Michal Koscik (Czech Republic); Phoebe Li (United Kingdom); Pin Lean Lau (United Kingdom); Aurélie Mahalatchimy (France); Jean McHale (United Kingdom); Isabelle Moine-Dupuis (France); Andrea Mulligan (Ireland); Stefania Negri (Italy); Vera Lucia Raposo (Portugal); Emmanuelle Rial-Sebbag (France); Sabrina Roettger-Wirtz (The Netherlands); Judit Sandor (Hungary); Mike Schwebag (Luxembourg); Claudia Seitz (Switzerland); Santa Slokenberga (Sweden); Tomislav Sokol (Croatia).

Chairs: Aurélie Mahalatchimy (UMR 7318 DICE CERIC, CNRS, Aix Marseille University, Toulon University, Pau & Pays de l’Adour University, France) and Mark Flear (Queen’s University Belfast, UK)

General manager: Pin Lean Lau (Brunel University, UK)

Communication managers: Mirko Dukovic (Central European University, Hungary) and Edouard Habib (Aix-Marseille University, France)

Should you need any information on the group, please contact our General Manager, Dr Pin Lean Lau: PinLean.Lau@brunel.ac.uk

 

Activities of the EAHL Interest Group on Supranational Biolaw

 

Since its launch, the IG has conducted the following activities, thanks to the involvement of several of its members.

 

Conferences

-       Panel on “The Constitution of Biopolitics in the 21st Century” selected for The Global Summit organized by The International Forum on the Future of Constitutionalism, Virtual Conference held on 12-16 January 2021 (https://law.utexas.edu/the-global-summit/virtual-schedule/day-4/concurrent-sessions-17/) involving

             Chair: Mirko DUKOVIC (Central European University)

Panellists from the EAHL IG:

A. MAHALATCHIMY and M. FLEAR, Bioconstitutionalism in the European Union regulation of gene-editing technologies

P. L. LAU, ‘Zombie’ Apocalypses, the Black Death, and Virulent Gene-Edited Pathogens: Evolving Bio-Constitutional Legal Responses for Global Bio-Security,

M. DUKOVIC, Human Body as Crux: Covid19 challenges to Bioconstitutionalism

The Interest Group is very proud of M. DUKOVIC (PhD student) for his first selection and perfect chairing of a panel in a conference of this scale!

 

-       Virtual Symposium on “Law, Biomedical Technoscience and Imaginaries”, Journal of Law and the Biosciences, 4 February 2021

Chair: Mark FLEAR (Queen’s University Belfast)

Panellists from the EAHL IG:

M. FLEAR, Expectations as Techniques of Legitimation? Imaginaries in Global Bioethics Standards for the Regulation of Health Research

A. MAHALATCHIMY, P. L. LAU, P. LI, M. FLEAR, Framing and legitimating EU legal regulation of human gene-editing technologies: key facets and functions of an imaginary

 

Publications

 

  • Special issue on “Law, Biomedical Technoscience and Imaginaries” in the Journal of Law and the Biosciences

Editor: Mark FLEAR (Queen’s University Belfast) (with co-editor R. Ashcroft)

With papers from members of the IG:

M. FLEAR (with R. Ashcroft), Guest Editorial: Law, Biomedical Technoscience and Imaginaries

M. FLEAR, Expectations as Techniques of Legitimation? Imaginaries in Global Bioethics Standards for the Regulation of Health Research

A. MAHALATCHIMY, P. L. LAU, P. LI, M. FLEAR, Framing and legitimating EU legal regulation of human gene-editing technologies: key facets and functions of an imaginary

The Special Issue will be published soon, we will keep you posted and hope you will enjoy it!

 

  • The Oxford Handbook on Comparative Health Law

Editor: Tamara K. HERVEY (City, University of London) (with co-editor D. Orentlicher)

With chapters from members of the IG:

J. CAYON-DE LAS CUEVAS, Organ Transplantation (with D. Orentlicher)

M. FRISCHHUT, Communicable and Other Infectious Diseases: The EU Perspective; and Introduction to Public Health Law (with W. E. Parmet, A. Garde, and B. Toebes)

T. K. HERVEY, Editors’ Introduction to The Oxford Handbook of Comparative Health Law (with D. Orentlicher)

A.MAHALATCHIMY, Regulating Medicines in the European Union; Regulating Medical Devices in the European Union; and Introduction to Medical Products Law (with E. Lietzan and P. Zettler)

J. SANDOR, Decisions at the End of Life (with D. Orentlicher)

The Oxford Handbook on Comparative Health Law has been published online, and the paper book will be published soon. We will keep you posted and hope you will enjoy it!

 

  • Book “Innovation et Analyse des risques dans le domaine de la santé et des produits de santé dans l’Union Européenne : regards croisés”, Cahiers Jean Monnet, Presses de l’Université Toulouse 1 Capitole

Editor: N. DE GROVE-VALDEYRON (University of Toulouse 1- Capitole)

With chapters from members of the IG:

N. DE GROVE-VALDEYRON, Dispositifs médicaux connectés et innovation technologique : quel rôle pour la normalisation européenne ?

A.MAHALATCHIMY and E. RIAL-SEBBAG, Le génome humain édité : risques et gouvernance

N. DUBRUEL & É. GENNET, « L’encadrement éthique et juridique des essais in silico en droit européen »

More information on this book here.

 

  • The Health Law part of the OUP online encyclopaedia on EU Law

Editor: Tamara K. HERVEY (City, University of London)

With chapters from other members of the IG: J. CAYON-DE LAS CUEVAS, N. DE GROVE-VALDEYRON, M. FLEAR, E. GENNET, A.MAHALATCHIMY.

This work is ongoing!

 

 

Projects

-       The common answer from several IG members to WHO call on Anti- Microbial Resistance.

       Lead: Phoebe LI (University of Sussex)

Other EAHL IG Members involved are: D. BACH-GOLECKA, J. CAYON, B. DALY, M. DUKOVIC, M. GUERRIAUD, M. KOSCIK, P. L. LAU, A. MAHALATCHIMY.

The project has been selected by WHO! It is running from May to October 2021, further information on the results will be communicated in accordance with WHO.

 

  • The common answer from several IG members to the call for 2021 Thematic Networks under the EU Health Policy Platform, European Commission on “Health as a fundamental value: Towards an inclusive and equitable pharmaceutical strategy for the EU”

Leads: Eloïse GENNET and Aurélie MAHALATCHIMY (University of Aix-Marseille, UMR 7318 DICE CERIC)

Other EAHL IG Members involved are: J. CAYON-DE LAS CUEVAS, B. DALY, A.-M. DUGUET, C. FORTIER, M. FRISCHHUT, N. DE GROVE-VALDEYRON, SM. DUKOVIC, M. GUERRIAUD, M. KOSCIK, P. L. LAU, I. MOINE-DUPUIS, S. ROETTGER-WIRTZ.

The proposal has been shortlisted among the 5 semi-finalists by the European Commission.

 

Information added: *05.03.2020

Updated: 06.07.2021